Regulation of mammary gland branching morphogenesis by the extracellular matrix and its remodeling enzymes

Breast Cancer Research

Volumn 6, Issue 1, 2004, Pages 1-11

  Fata, Jimmie E ^a   Werb, Zena ^b   Bissell, Mina J ^a  

^a LAWRENCE BERKELEY NATIONAL LABORATORY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Branching morphogenesis; Extracellular matrix (ECM); Integrins; Mammary gland; Matrix metalloproteinases (MMPs) tissue inhibitors of MMPs (TIMPs)

Indexed keywords

CELL ENZYME; CELL RECEPTOR; INTEGRIN; MATRIX METALLOPROTEINASE; MATRIX METALLOPROTEINASE INHIBITOR; EXTRACELLULAR MATRIX RECEPTOR; INTEGRIN RECEPTOR; RECEPTOR; TISSUE INHIBITOR OF METALLOPROTEINASE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; BRANCHING MORPHOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; CANCER INVASION; CELL ADHESION; CELL CULTURE; CELL DIFFERENTIATION; CELL INVASION; CELL MIGRATION; CELL POLARITY; CELL PROLIFERATION; CELL SURVIVAL; EXTRACELLULAR MATRIX; GENETIC MANIPULATION; HUMAN; MAMMARY GLAND; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; BREAST; BREAST DEVELOPMENT; CANCER CELL; MAMMARY GLAND BRANCHING MORPHOGENESIS; NONHUMAN;

ANIMALS; EXTRACELLULAR MATRIX; FEMALE; INTEGRINS; MAMMARY GLANDS, ANIMAL; MATRIX METALLOPROTEINASES; MICE; MODELS, BIOLOGICAL; MORPHOGENESIS; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 1042292614     PISSN: 14655411     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (140)

1. Wicha MS, Liotta LA, Vonderhaar BK, Kidwell WR: Effects of inhibition of basement membrane collagen deposition on rat mammary gland development. Dev Biol 1980, 80:253-256.
2. Gumbiner BM: Epithelial morphogenesis. Cell 1992, 69:385-387.
3. Affolter M, Bellusci S, Itoh N, Shilo B, Thiery JP, Werb Z: Tube or not tube: remodeling epithelial tissues by branching morphogenesis. Dev Cell 2003, 4:11-18.
4. Hogan BL: Morphogenesis. Cell 1999, 96:225-233.
5. Horster MF, Braun GS, Huber SM: Embryonic renal epithelia: induction, nephrogenesis, and cell differentiation. Physiol Rev 1999, 79:1157-1191.
6. Morita K, Nogawa H: EGF-dependent lobule formation and FGF7-dependent stalk elongation in branching morphogenesis of mouse salivary epithelium in vitro. Dev Dyn 1999, 215: 148-154.
7. Fukuda Y, Masuda Y, Kishi J, Hashimoto Y, Hayakawa T, Nogawa H, Nakanishi Y: The role of interstitial collagens in cleft formation of mouse embryonic submandibular gland during initial branching. Development 1988, 103:259-267.
8. Daniel CW, Smith GH: The mammary gland: a model for development. J Mammary Gland Biol Neoplasia 1999, 4:3-8.
9. Hennighausen L, Robinson GW: Signaling pathways in mammary gland development. Dev Cell 2001, 1:467-475.
10. Wiseman BS, Werb Z: Stromal effects on mammary gland development and breast cancer. Science 2002, 296:1046-1049.
11. Robinson GW, Karpf AB, Kratochwil K: Regulation of mammary gland development by tissue interaction. J Mammary Gland Biol Neoplasia 1999, 4:9-19.
12. Fata JE, Leco KJ, Moorehead RA, Martin DC, Khokha R: Timp-1 is important for epithelial proliferation and branching morphogenesis during mouse mammary development. Dev Biol 1999, 211:238-254.
13. Fata JE, Chaudhary V, Khokha R: Cellular turnover in the mammary gland is correlated with systemic levels of progesterone and not 17beta-estradiol during the estrous cycle. Biol Reprod 2001, 65:680-688.
14. Andres AC, Strange R: Apoptosis in the estrous and menstrual cycles. J Mammary Gland Biol Neoplasia 1999, 4:221-228.
15. Ferguson JE, Schor AM, Howell A, Ferguson MW: Changes in the extracellular matrix of the normal human breast during the menstrual cycle. Cell Tissue Res 1992, 268:167-177.
16. Robinson GW, Hennighausen L, Johnson PF: Side-branching in the mammary gland: the progesterone-Wnt connection. Genes Dev 2000, 14:889-894.
17. Osborne MP: Breast Development and Anatomy. Philadelphia: Lippincott-Raven Publishers; 1996.
18. Russo J, Russo IH: Development pattern of human breast and susceptibility to carcinogenesis. Eur J Cancer Prev 1993, 3:85-100.
19. Emerman JT, Vogl AW: Cell size and shape changes in the myoepithelium of the mammary gland during differentiation. Anat Rec 1986, 216:405-415.
20. Gudjonsson T, Ronnov-Jessen L, Villadsen R, Rank F, Bissell MJ, Petersen OW: Normal and tumor-derived myoepithelial cells differ in their ability to interact with luminal breast epithelial cells for polarity and basement membrane deposition. J Cell Sci 2002, 115:39-50.
21. Silberstein GB, Daniel CW: Glycosaminoglycans in the basal lamina and extracellular matrix of the developing mouse mammary duct. Dev Biol 1982, 90:215-222.
22. Lochter A, Bissell MJ: Involvement of extracellular matrix constituents in breast cancer. Semin Cancer Biol 1995, 6:165-173.
23. Silberstein GB, Strickland P, Coleman S, Daniel CW: Epithelium-dependent extracellular matrix synthesis in transforming growth factor-beta 1 -growth-inhibited mouse mammary gland. J Cell Biol 1990, 110:2209-2219.
24. Alford D, Taylor-Papadimitriou J: Cell adhesion molecules in the normal and cancerous mammary gland. J Mammary Gland Biol Neoplasia 1996, 1:207-218.
25. Weaver VM, Petersen OW, Wang F, Larabell CA, Briand P, Damsky C, Bissell MJ: Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies. J Cell Biol 1997, 137:231-245.
26. Elenius K, Salmivirta M, Inki P, Mali M, Jalkanen M: Binding of human syndecan to extracellular matrix proteins. J Biol Chem 1990, 265:17837-17843.
27. Barcellos-Hoff MH: Mammary epithelial reorganization on extracellular matrix is mediated by cell surface galactosyltransferase. Exp Cell Res 1992, 201:225-234.
28. Belkin AM, Smalheiser NR: Localization of cranin (dystroglycan) at sites of cell-matrix and cell-cell contact: recruitment to focal adhesions is dependent upon extracellular ligands. Cell Adhes Commun 1996, 4:281-296.
29. Warfield PR, Makker PN, Raz A, Ochieng J: Adhesion of human breast carcinoma to extracellular matrix proteins is modulated by galectin-3. Invasion Metastasis 1997, 17:101-112.
30. Klinowska TC, Alexander CM, Georges-Labouesse E, Van der NR, Kreidberg JA, Jones CJ, Sonnenberg A, Streuli CH: Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits. Dev Biol 2001, 233:449-467.
31. Chen J, Diacovo TG, Grenache DG, Santoro SA, Zutter MM: The alpha(2) integrin subunit-deficient mouse: a multifaceted phenotype including defects of branching morphogenesis and hemostasis. Am J Pathol 2002,161:337-344.
32. Berdichevsky F, Alford D, D'Souza B, Taylor-Papadimitriou J: Branching morphogenesis of human mammary epithelial cells in collagen gels. J Cell Sci 1994, 107:3557-3568.
33. Stahl S, Weitzman S, Jones JC: The role of laminin-5 and its receptors in mammary epithelial cell branching morphogenesis. J Cell Sci 1997, 110:55-63.
34. Klinowska TC, Alexander CM, Georges-Labouesse E, Van der Neut R, Kreidberg JA, Jones CJ, Sonnenberg A, Streuli CH: Epithelial development and differentiation in the mammary gland is not dependent on alpha 3 or alpha 6 integrin subunits. Dev Biol 2001, 233:449-467.
35. Klinowska TC, Soriano JV, Edwards GM, Oliver JM, Valentijn AJ, Montesano R, Streuli CH: Laminin and beta1 integrins are crucial for normal mammary gland development in the mouse. Dev Biol 1999, 215:13-32.
36. Afford D, Baeckstrom D, Geyp M, Pitha P, Taylor-Papadimitriou J: Integrin-matrix interactions affect the form of the structures developing from human mammary epithelial cells in collagen or fibrin gels. J Cell Sci 1998, 111:521-532.
37. Arnaout MA, Goodman SL, Xiong JP: Coming to grips with integrin binding to ligands. Curr Opin Cell Biol 2002, 14:641-651.
38. Hathaway HJ, Shur BD: Mammary gland morphogenesis is inhibited in transgenic mice that overexpress cell surface beta1,4-galactosyltransferase. Development 1996, 122:2859-2872.
39. Muschler J, Levy D, Boudreau R, Henry M, Campbell K, Bissell MJ: A role for dystroglycan in epithelial polarization: loss of function in breast tumor cells. Cancer Res 2002, 62:7102-7109.
40. Durbeej M, Ekblom P: Dystroglycan and laminins: glycoconjugates involved in branching epithelial morphogenesis. Exp Lung Res 1997, 23:109-118.
41. Vogel WF: Collagen-receptor signaling in health and disease. Eur J Dermatol 2001, 11:506-514.
42. Vogel WF, Aszodi A, Alves F, Pawson T: Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development. Mol Cell Biol 2001, 21:2906-2917.
43. Bullock SL, Johnson TM, Bao Q, Hughes RC, Winyard PJ, Woolf AS: Galectin-3 modulates ureteric bud branching in organ culture of the developing mouse kidney. J Am Soc Nephrol 2001, 12:515-523.
44. Wessells NK, Cohen JH: Effects of collagenase on developing epithelia in vitro: lung, ureteric bud, and pancreas. Dev Biol 1968, 18:294-309.
45. Banerjee SD, Cohn RH, Bernfield MR: Basal lamina of embryonic salivary epithelia. Production by the epithelium and role in maintaining lobular morphology. J Cell Biol 1977, 73:445-463.
46. Nakanishi Y, Sugiura F, Kishi J, Hayakawa T: Collagenase inhibitor stimulates cleft formation during early morphogenesis of mouse salivary gland. Dev Biol 1986, 113:201-206.
47. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA: Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001, 155:459-470.
48. Rytomaa M, Lehmann K, Downward J: Matrix detachment induces caspase-dependent cytochrome c release from mitochondria: inhibition by PKB/Akt but not Raf signalling. Oncogene 2000, 19:4461-4468.
49. Felbor U, Dreier L, Bryant RA, Ploegh HL, Olsen BR, Mothes W: Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J 2000, 19:1187-1194.
50. Giannelli G, Falk-Marzillier J, Schiraldi O, Stetler-Stevenson WG, Quaranta V: Induction of cell migration by matrix metalloprotease-2 cleavage of laminin-5. Science 1997, 277:225-228.
51. Whitelock JM, Murdoch AD, Iozzo RV, Underwood PA: The degradation of human endothelial cell-derived perlecan and release of bound basic fibroblast growth factor by stromelysin, collagenase, plasmin, and heparanases. J Biol Chem 1996, 271:10079-10086.
52. Bashkin P, Doctrow S, Klagsbrun M, Svahn CM, Folkman J, Vlodavsky I: Basic fibroblast growth factor binds to subendothelial extracellular matrix and is released by heparitinase and heparin-like molecules. Biochemistry 1989, 28:1737-1743.
53. Sinha S, Nevett C, Shuttleworth CA, Kielty CM: Cellular and extracellular biology of the latent transforming growth factor-beta binding proteins. Matrix Biol 1998, 17:529-545.
54. Quarto N, Amalric F: Heparan sulfate proteoglycans as transducers of FGF-2 signalling. J Cell Sci 1994, 107:3201-3212.
55. Ito K, Okamoto I, Araki N, Kawano Y, Nakao M, Fujiyama S, Tomita K, Mimori T, Saya H: Calcium influx triggers the sequential proteolysis of extracellular and cytoplasmic domains of E-cadherin, leading to loss of beta-catenin from cell-cell contacts. Oncogene 1999, 18:7080-7090.
56. Noe V, Fingleton B, Jacobs K, Crawford HC, Vermeulen S, Steelant W, Bruyneel E, Matrisian LM, Mareel M: Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J Cell Sci 2001, 114:111-118.
57. Lochter A, Galosy S, Muschler J, Freedman N, Werb Z, Bissell MJ: Matrix metalloproteinase stromelysin-1 triggers a cascade of molecular alterations that leads to stable epithelial-to-mesenchymal conversion and a premalignant phenotype in mammary epithelial cells. J Cell Biol 1997, 139:1861-1872.
58. Schlondorff J, Blobel CP: Metalloprotease-disintegrins: modular proteins capable of promoting cell-cell interactions and triggering signals by protein-ectodomain shedding. J Cell Sci 1999, 112:3603-3617.
59. Werb Z, Yan Y: A cellular striptease act. Science 1998, 282: 1279-1280.
60. Nelson AR, Fingleton B, Rothenberg ML, Matrisian LM: Matrix metalloproteinases: biologic activity and clinical implications. J Clin Oncol 2000, 18:1135-1149.
61. Birkedal-Hansen H, Moore WG, Bodden MK, Windsor LJ, Birkedal-Hansen B, DeCarlo A, Engler JA: Matrix metalloproteinases: a review. Crit Rev Oral Biol Med 1993, 4:197-250.
62. Egeblad M, Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev, Cancer 2002, 2:161-174.
63. Infeld MD: Cell-matrix interactions in gland development in the lung. Exp Lung Res 1997, 23:161-169.
64. Fukuda Y, Ishizaki M, Okada Y, Seiki M, Yamanaka N: Matrix metalloproteinases and tissue inhibitor of metalloproteinase-2 in fetal rabbit lung. Am J Physiol Lung Cell Mol Physiol 2000, 279: 555-561.
65. Baker SE, Hopkinson SB, Fitchmun M, Andreason GL, Frasier F, Plopper G, Quaranta V, Jones JC: Laminin-5 and hemidesmosomes: role of the alpha 3 chain subunit in hemidesmosome stability and assembly. J Cell Sci 1996, 109:2509-2520.
66. Lelongt B, Trugnan G, Murphy G, Ronco PM: Matrix metalloproteinases MMP2 and MMP9 are produced in early stages of kidney morphogenesis but only MMP9 is required for renal organogenesis in vitro. J Cell Biol 1997, 136:1363-1373.
67. Hayakawa T, Kishi J, Nakanishi Y: Salivary gland morphogenesis: possible involvement of collagenase. Matrix Suppl 1992, 1: 344-351.
68. Talhouk RS, Chin JR, Unemori EN, Werb Z, Bissell MJ: Proteinases of the mammary gland: developmental regulation in vivo and vectorial secretion in culture. Development 1991, 112: 439-449.
69. Witty JP, Wright JH, Matrisian LM: Matrix metalloproteinases are expressed during ductal and alveolar mammary morphogenesis, and misregulation of stromelysin-1 in transgenic mice induces unscheduled alveolar development. Mol Biol Cell 1995, 6:1287-1303.
70. Sympson CJ, Talhouk RS, Alexander CM, Chin JR, Clift SM, Bissell MJ, Werb Z: Targeted expression of stromelysin-1 in mammary gland provides evidence for a role of proteinases in branching morphogenesis and the requirement for an intact basement membrane for tissue-specific gene expression. J Cell Biol 1994, 125:681-693.
71. Sternlicht MD, Lochter A, Sympson CJ, Huey B, Rougier JP, Gray JW, Pinkel D, Bissell MJ, Werb Z: The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis. Cell 1999, 98:137-146.
72. Ha HY, Moon HB, Nam MS, Lee JW, Ryoo ZY, Lee TH, Lee KK, So BJ, Sato H, Seiki M, Yu DY: Overexpression of membrane-type matrix metalloproteinase-1 gene induces mammary gland abnormalities and adenocarcinoma in transgenic mice. Cancer Res 2001, 61:984-990.
73. Rudolph-Owen LA, Chan R, Muller WJ, Matrisian LM: The matrix metalloproteinase matrilysin influences early-stage mammary tumorigenesis. Cancer Res 1998, 58:5500-5506.
74. Kheradmand F, Rishi K, Werb Z: Signaling through the EGF receptor controls lung morphogenesis in part by regulating MT1-MMP-mediated activation of gelatinase A/MMP2. J Cell Sci 2002, 115:839-848.
75. Hotary K, Allen E, Punturieri A, Yana I, Weiss SJ: Regulation of cell invasion and morphogenesis in a three-dimensional type I collagen matrix by membrane-type matrix metalloproteinases 1, 2, and 3. J Cell Biol 2000, 149:1309-1323.
76. Desprez PY, Roskelley CD, Campisi J, Bissell MJ: Isolation of functional cell lines from a mouse mammary epithelial cell strain: the importance of basement membrane and cell-cell interactions. Mol Cell Diff 1993, 1:99-110.
77. Simian M, Hirai Y, Navre M, Werb Z, Lochter A, Bissell MJ: The interplay of matrix metalloproteinases, morphogens and growth factors is necessary for branching of mammary epithelial cells. Development 2001, 128:3117-3131.
78. Hay ED: An overview of epithelio-mesenchymal transformation. Acta Anat (Basel) 1995, 154:8-20.
79. Hirai Y, Lochter A, Galosy S, Koshida S, Niwa S, Bissell MJ: Epimorphin functions as a key morphoregulator for mammary epithelial cells. J Cell Biol 1998, 140:159-169.
80. Hirai Y, Radisky D, Boudreau R, Simian M, Stevens ME, Oka Y, Takebe K, Niwa S, Bissell MJ: Epimorphin mediates mammary luminal morphogenesis through control of C/EBPbeta. J Cell Biol 2001, 153:785-794.
81. Irigoyen JP, Munoz-Canoves P, Montero L, Koziczak M, Nagamine Y: The plasminogen activator system: biology and regulation. Cell Mol Life Sci 1999, 56:104-132.
82. Lund LR, Bjorn SF, Sternlicht MD, Nielsen BS, Solberg H, Usher PA, Osterby R, Christensen IJ, Stephens RW, Bugge TH, Dano K, Werb Z: Lactational competence and involution of the mouse mammary gland require plasminogen. Development 2000, 127:4481-4492.
83. Selvarajan S, Lund LR, Takeuchi T, Craik CS, Werb Z: A plasma kallikrein-dependent plasminogen cascade required for adipocyte differentiation. Nat Cell Biol 2001, 3:267-275.
84. Ganser GL, Stricklin GP, Matrisian LM: EGF and TGF alpha influence in vitro lung development by the induction of matrix-degrading metalloproteinases. Int J Dev Biol 1991, 35:453-461.
85. Kanwar YS, Ota K, Yang O, Wada J, Kashihara N, Tian Y, Wallner EI: Role of membrane-type matrix metalloproteinase 1 (MT-1-MMP), MMP-2, and its inhibitor in nephrogenesis. Am J Physiol 1999, 277:934-947.
86. Vu TH, Werb Z: Matrix metalloproteinases: effectors of development and normal physiology. Genes Dev 2000, 14:2123-2133.
87. Koshikawa N, Giannelli G, Cirulli V, Miyazaki K, Quaranta V: Role of cell surface metalloprotease MT1-MMP in epithelial cell migration over laminin-5. J Cell Biol 2000, 148:615-624.
88. Hayakawa T, Yamashita K, Tanzawa K, Uchijima E, Iwata K: Growth-promoting activity of tissue inhibitor of metalloproteinases-1 (TIMP-1) for a wide range of cells. A possible new growth factor in serum. FEBS Lett 1992, 298:29-32.
89. Hayakawa T, Yamashita K, Ohuchi E, Shinagawa A: Cell growth-promoting activity of tissue inhibitor of metalloproteinases-2 (TIMP-2). J Cell Sci 1994, 107:2373-2379.
90. Ellerbroek SM, Stack MS: Membrane associated matrix metalloproteinases in metastasis. Bioessays 1999, 21:940-949.
91. Kadono Y, Shibahara K, Namiki M, Watanabe Y, Seiki M, Sato H: Membrane type 1-matrix metalloproteinase is involved in the formation of hepatocyte growth factor/scatter factor-induced branching tubules in madin-clarby canine kidney epithelial cells. Biochem Biophys Res Commun 1998, 251:681-687.
92. Amour A, Slocombe PM, Webster A, Butler M, Knight CG, Smith BJ, Stephens PE, Shelley C, Hutton M, Knauper V, Docherty AJ, Murphy G: TNF-alpha converting enzyme (TACE) is inhibited by TIMP-3. FEBS Lett 1998, 435:39-44.
93. Yu WH, Yu S, Meng Q, Brew K, Woessner JF Jr.: TIMP-3 binds to sulfated glycosaminoglycans of the extracellular matrix. J Biol Chem 2000, 275:31226-31232.
94. Fata JE, Leco KJ, Voura EB, Yu HY, Waterhouse P, Murphy G, Moorehead RA, Khokha R: Accelerated apoptosis in the Timp-3-deficient mammary gland. J Clin Invest 2001, 108:831-841.
95. Lilla J, Stickens D, Werb Z: Metalloproteases and adipogenesis: a weighty subject. Am J Pathol 2002, 160:1551-1554.
96. Wolf K, Mazo I, Leung H, Engelke K, von Andrian UH, Deryugina EI, Strongin AY, Brocker EB, Friedl P: Compensation mechanism in tumor cell migration: mesenchymal-amoeboid transition after blocking of pericellular proteolysis. J Cell Biol 2003, 160:267-277.
97. Williams JM, Daniel CW: Mammary ductal elongation: differentiation of myoepithelium and basal lamina during branching morphogenesis. Dev Biol 1983, 97:274-290.
98. Petersen OW, Lind NH, Gudjonsson T, Villadsen R, Ronnov-Jessen L, Bissell MJ: The plasticity of human breast carcinoma cells is more than epithelial to mesenchymal conversion. Breast Cancer Res 2001, 3:213-217.
99. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Bernards R, Friend SH: Expression profiling predicts outcome in breast cancer. Breast Cancer Res 2002, 5:57-58.
100. van de Vijver MJ, He YD, van't Veer LJ, Dai H, Hart AA, Voskuil DW, Schreiber GJ, Peterse JL, Roberts C, Marton MJ, Parrish M, Atsma D, Witteveen A, Glas A, Delahaye L, van der Velde T, Bartelink H, Rodenhuis S, Rutgers ET, Friend SH, Bernards R: A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med 2002, 347:1999-2009.
101. Wang W, Wyckoff JB, Frohlich VC, Oleynikov Y, Huttelmaier S, Zavadil J, Cermak L, Bottinger EP, Singer RH, White JG, Segall JE, Condeelis JS: Single cell behavior in metastatic primary mammary tumors correlated with gene expression patterns revealed by molecular profiling. Cancer Res 2002, 62:6278-6288.
102. Thompson EW, Yu M, Bueno J, Jin L, Maiti SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R, Wapnir I, et al.: Collagen induced MMP-2 activation in human breast cancer. Breast Cancer Res Treat 1994, 31:357-370.
103. Lagace R, Grimaud JA, Schurch W, Seemayer TA: Myofibroblastic stromal reaction in carcinoma of the breast: variations of collagenous matrix and structural glycoproteins. Virchows Arch A Pathol Anat Histopathol 1985, 408:49-59.
104. Wetzels RH, Robben HC, Leigh IM, Schaafsma HE, Vooijs GP, Ramaekers FC: Distribution patterns of type VII collagen in normal and malignant human tissues. Am J Pathol 1991, 139: 451-459.
105. Barsky SH, Rao CN, Grotendorst GR, Liotta LA: Increased content of Type V Collagen in desmoplasia of human breast carcinoma. Am J Pathol 1982, 108:276-283.
106. D'Ardenne AJ, Richman PI, Horton MA, McAulay AE, Jordan S: Co-ordinate expression of the alpha-6 integrin laminin receptor sub-unit and laminin in breast cancer. J Pathol 1991, 165: 213-220.
107. Rudolph-Owen LA, Matrisian LM: Matrix metalloproteinases in remodeling of the normal and neoplastic mammary gland. J Mammary Gland Biol Neoplasia 1998, 3:177-189.
108. Zutter MM, Mazoujian G, Santoro SA: Decreased expression of integrin adhesive protein receptors in adenocarcinoma of the breast. Am J Pathol 1990, 137:863-870.
109. Zutter MM, Krigman HR, Santoro SA: Altered integrin expression in adenocarcinoma of the breast. Analysis by in situ hybridization. Am J Pathol 1993, 142:1439-1448.
110. Warner MR: Effect of various doses of estrogen to BALB/cCrgl neonatal female mice on mammary growth and branching at 5 weeks of age. Cell Tissue Kinet 1976, 9:429-438.
111. Daniel CW, Silberstein GB, Strickland P: Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography. Cancer Res 1987, 47:6052-6057.
112. Silberstein GB, Van Horn K, Shyamala G, Daniel CW: Essential role of endogenous estrogen in directly stimulating mammary growth demonstrated by implants containing pure antiestrogens. Endocrinology 1994, 134:84-90.
113. Atwood CS, Hovey RC, Glover JP, Chepko G, Ginsburg E, Robison WG, Vonderhaar BK: Progesterone induces side-branching of the ductal epithelium in the mammary glands of peripubertal mice. J Endocrinol 2000, 167:39-52.
114. Wysolmerski JJ, Philbrick WM, Dunbar ME, Lanske B, Kronenberg H, Broadus AE: Rescue of the parathyroid hormone-related protein knockout mouse demonstrates that parathyroid hormone-related protein is essential for mammary gland development. Development 1998, 125:1285-1294.
115. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM: Overexpression of parathyrold hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development 1995, 121:3539-3547.
116. Zhu Z, Jiang W, Thompson HJ: Effect of corticosterone administration on mammary gland development and p27 expression and their relationship to the effects of energy restriction on mammary carcinogenesis. Carcinogenesis 1998, 19:2101-2106.
117. Coleman S, Silberstein GB, Daniel CW: Ductal morphogenesis in the mouse mammary gland: evidence supporting a role for epidermal growth factor. Dev Biol 1988, 127:304-315.
118. Robinson SD, Silberstein GB, Roberts AB, Flanders KC, Daniel CW: Regulated expression and growth inhibitory effects of transforming growth factor-beta isoforms in mouse mammary gland development. Development 1991, 113:867-878.
119. Silberstein GB, Daniel CW: Reversible inhibition of mammary gland growth by transforming growth factor-beta. Science 1987, 237:291-293.
120. Ruan W, Kleinberg DL: Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development. Endocrinology 1999, 140: 5075-5081.
121. Yant J, Buluwela L, Niranjan B, Gusterson B, Kamalati T: In vivo effects of hepatocyte growth factor/scatter factor on mouse mammary gland development. Exp Cell Res 1998, 241:476-481.
122. Bani G, Bigazzi M, Bani D: The effects of relaxin on the mouse mammary gland. II. The epithelium. J Endocrinol Invest 1986, 9:145-152.
123. Kenney NJ, Smith GH, Rosenberg K, Cutler ML, Dickson RB: Induction of ductal morphogenesis and lobular hyperplasia by amphiregulin in the mouse mammary gland. Cell Growth Differ 1996, 7:1769-1781.
124. Jones FE, Jerry DJ, Guarino BC, Andrews GC, Stern DF: Heregulin induces in vivo proliferation and differentiation of mammary epithelium into secretory lobuloalveoli. Cell Growth Differ 1996, 7:1031-1038.
125. Brisken C, Heineman A, Chavarria T, Elenbaas B, Tan J, Dey SK, McMahon JA, McMahon AP, Weinberg RA: Essential function of Wnt-4 in mammary gland development downstream of progesterone signaling. Genes Dev 2000, 14:650-654.
126. Bradbury JM, Edwards PA, Niemeyer CC, Dale TC: Wnt-4 expression induces a pregnancy-like growth pattern in reconstituted mammary glands in virgin mice. Dev Biol 1995, 170: 553-563.
127. Mukherjee S, Louie SG, Campbell M, Esserman L, Shyamala G: Ductal growth is impeded in mammary glands of C-neu transgenic mice. Oncogene 2000, 19:5982-5987.
128. Gouon-Evans V, Rothenberg ME, Pollard JW: Postnatal mammary gland development requires macrophages and eosinophils. Development 2000, 127:2269-2282.
129. Wiesen JF, Young P, Werb Z, Cunha GR: Signaling through the stromal epidermal growth factor receptor is necessary for mammary ductal development. Development 1999, 126:335-344.
130. Xie W, Paterson AJ, Chin E, Nabell LM, Kudlow JE: Targeted expression of a dominant negative epidermal growth factor receptor in the mammary gland of transgenic mice inhibits pubertal mammary duct development. Mol Endocrinol 1997, 11:1766-1781.
131. Bocchinfuso WP, Lindzey JK, Hewitt SC, Clark JA, Myers PH, Cooper R, Korach KS: Induction of mammary gland development in estrogen receptor-alpha knockout mice. Endocrinology 2000, 141:2982-2994.
132. Shyamala G, Yang X, Silberstein G, Barcellos-Hoff MH, Dale E: Transgenic mice carrying an imbalance in the native ratio of A to B forms of progesterone receptor exhibit developmental abnormalities in mammary glands. Proc Natl Acad Sci USA 1998, 95:696-701.
133. Lydon JP, DeMayo FJ, Funk CR, Mani SK, Hughes AR, Montgomery CA, Jr, Shyamala G, Conneely OM, O'Malley BW: Mice lacking progesterone receptor exhibit pleiotropic reproductive abnormalities. Genes Dev 1995, 9:2266-2278.
134. Brisken C, Kaur S, Chavarria TE, Binart N, Sutherland RL, Weinberg RA, Kelly PA, Ormandy CJ: Prolactin controls mammary gland development via direct and indirect mechanisms. Dev Biol 1999, 210:96-106.
135. Joseph H, Gorska AE, Sohn P, Moses HL, Serra R: Overexpression of a kinase-deficient transforming growth factor-beta type II receptor in mouse mammary stroma results in increased epithelial branching. Mol Biol Cell 1999, 10:1221-1234.
136. Seagroves TN, Krnacik S, Raught B, Gay J, Burgess-Beusse B, Darlington GJ, Rosen JM: C/EBPbeta, but not C/EBPalpha, is essential for ductal morphogenesis, lobuloalveolar proliferation, and functional differentiation in the mouse mammary gland. Genes Dev 1998, 12:1917-1928.
137. Robinson GW, Johnson PF, Hennighausen L, Sterneck E: The C/EBPbeta transcription factor regulates epithelial cell proliferation and differentiation in the mammary gland. Genes Dev 1998, 12:1907-1916.
138. Crowley MR, Head KL, Kwiatkowski DJ, Asch HL, Asch BB: The mouse mammary gland requires the actin-binding protein gelsolin for proper ductal morphogenesis. Dev Biol 2000, 225: 407-423.
139. Garcia-Gasca A, Spyropoulos DD: Differential mammary morphogenesis along the anteroposterior axis in Hoxc6 gene targeted mice. Dev Dyn 2000, 219:261-276.
140. Darribere T, Skalski M, Cousin HL, Gaultier A, Montmory C, Alfandari D: Integrins: regulators of embryogenesis. Biol Cell 2000, 92:5-25.